| Liquid biopsy in endometrial cancer: new opportunities for personalized oncology L Muinelo-Romay, C Casas-Arozamena, M Abal International journal of molecular sciences 19 (8), 2311, 2018 | 97 | 2018 |
| Extracellular vesicles-based biomarkers represent a promising liquid biopsy in endometrial cancer C Herrero, A de la Fuente, C Casas-Arozamena, V Sebastian, M Prieto, ... Cancers 11 (12), 2000, 2019 | 37 | 2019 |
| Genomic profiling of uterine aspirates and cfDNA as an integrative liquid biopsy strategy in endometrial cancer C Casas-Arozamena, E Díaz, CP Moiola, L Alonso-Alconada, A Ferreiros, ... Journal of clinical medicine 9 (2), 585, 2020 | 28 | 2020 |
| Haemodynamic-dependent arrest of circulating tumour cells at large blood vessel bifurcations as new model for metastasis C Casas-Arozamena, A Otero-Cacho, B Carnero, C Almenglo, ... Scientific Reports 11 (1), 23231, 2021 | 16 | 2021 |
| Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression A Mota, SS Oltra, P Selenica, CP Moiola, C Casas-Arozamena, ... Oncogene 41 (13), 1835-1850, 2022 | 14 | 2022 |
| Noninvasive detection of microsatellite instability in patients with endometrial cancer C Casas‐Arozamena, CP Moiola, A Vilar, M Bouso, J Cueva, S Cabrera, ... International Journal of Cancer 152 (10), 2206-2217, 2023 | 8 | 2023 |
| Improving the Management of Endometrial Cancer Patients through the Use of Liquid Biopsy Analyses: A Case Report C Casas-Arozamena, A Cortegoso, R Pineiro-Perez, A Abalo, E Arias, ... International Journal of Molecular Sciences 23 (15), 8539, 2022 | 6 | 2022 |
| Endometrial Tumour Microenvironment C Casas-Arozamena, M Abal Tumor Microenvironments in Organs: From the Brain to the Skin–Part B, 215-225, 2021 | 5 | 2021 |
| Ascites-Derived Organoids to Depict Platinum Resistance in Gynaecological Serous Carcinomas AE Arias-Diaz, M Ferreiro-Pantin, J Barbazan, E Perez-Beliz, ... International Journal of Molecular Sciences 24 (17), 13208, 2023 | 2 | 2023 |
| 1133 ECLAI: personalized clinical management of endometrial cancer using liquid biopsy, genomics and artificial intelligence SV Moreno, V Modhukur, C Casas-Arozamena, JI Klett-Mingo, A Lawarde, ... International Journal of Gynecologic Cancer 34 (Suppl 1), 2024 | | 2024 |
| 1103 Combinatory analysis of CfDNA and CtDNA as a predictive and follow up tool to improve endometrial cancer management C Casas-Arozamena, A Cortegoso, A Abalo, CP Moiola, E Arias, ... International Journal of Gynecologic Cancer 34 (Suppl 1), 2024 | | 2024 |
| ROLE OF cfDNA AND ctDNA TO IMPROVE THE RISK STRATIFICATION AND THE DISEASE FOLLOW-UP IN PATIENTS WITH ENDOMETRIAL CANCER: TOWARDS THE CLINICAL APPLICATION C Casas-Arozamena, A Vilar, J Cueva, E Arias, V Sampayo, E Diaz, ... medRxiv, 2024.05. 20.24307623, 2024 | | 2024 |
| Method for isolating nucleic acids ADELAF GONZÁLEZ, MA Posada, LM ROMAY, CC AROZAMENA US Patent App. 17/773,895, 2022 | | 2022 |
